← Eichor
Condition: Infliximab Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Infliximab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Top Down Versus Step up in Pediatric Ulcerative Colitis
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT04999228Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Phase 2 · 9 location(s) · Rambam Health Care Campus · NCT05599347PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
NA · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT06758024InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06059989Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06136546High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04331639Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
NA · 6 location(s) · University of Glasgow · NCT07522528Swiss Dermatology Network of Targeted Therapies (SDNTT)
Phase N/A · 6 location(s) · Swiss Dermatology Network for Targeted Therapies · NCT01706692Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflamm
Phase N/A · 1 location(s) · Xijing Hospital · NCT06995170Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
Phase 4 · 1 location(s) · Fundación de Investigación Biomédica - Hospital Universitari · NCT05313620Precise Infliximab Exposure and Pharmacodynamic Control
Phase 2/Phase 3 · 11 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05660746Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT02638701TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
Phase 4 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07510191Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06453317Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Phase 4 · 4 location(s) · Xijing Hospital of Digestive Diseases · NCT07550673Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
NA · 1 location(s) · University of British Columbia · NCT07314606Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-
Phase 2 · 14 location(s) · University of Liverpool · NCT03684278Combined Immunosuppression for Pediatric Crohn's Disease
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT05043870Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Phase 3 · 3 location(s) · Odense University Hospital · NCT05947669Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
NA · 1 location(s) · Asan Medical Center · NCT06064864Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · 10 location(s) · Medical University Innsbruck · NCT06954311Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07385131Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Dis
NA · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT07123207Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Phase N/A · 9 location(s) · University of North Carolina, Chapel Hill · NCT07237516MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07470502Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed
Phase 2 · 1 location(s) · Naresh Bumma · NCT07657312Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Phase 4 · 1 location(s) · Erasmus Medical Center · NCT05552287TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Phase 4 · 1 location(s) · Asan Medical Center · NCT06051253Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Phase 4 · 1 location(s) · Taizhou Mabtech Pharmaceutical Co.,Ltd · NCT05906576Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Phase 4 · 15 location(s) · Belgian Inflammatory Bowel Disease Research and Development · NCT06113913
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.